SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001595585-22-000012
Filing Date
2022-03-02
Accepted
2022-03-02 16:35:30
Documents
17
Period of Report
2022-03-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcda-20220302.htm   iXBRL 8-K 39934
2 EX-99.1 valorupdatepressrelease.htm EX-99.1 7499
6 GRAPHIC tcda-20220302_g1.jpg GRAPHIC 5018
7 GRAPHIC valorupdatepressrelease001.jpg GRAPHIC 230332
8 GRAPHIC valorupdatepressrelease002.jpg GRAPHIC 260567
9 GRAPHIC valorupdatepressrelease003.jpg GRAPHIC 33410
  Complete submission text file 0001595585-22-000012.txt   928849

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20220302.xsd EX-101.SCH 1912
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20220302_lab.xml EX-101.LAB 25149
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20220302_pre.xml EX-101.PRE 13056
11 EXTRACTED XBRL INSTANCE DOCUMENT tcda-20220302_htm.xml XML 11324
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38558 | Film No.: 22704199
SIC: 2834 Pharmaceutical Preparations